Description | Pfixed-effect IVW | PMR-Egger | PWeighted-median | PMR-PRESSO | PMR-PRESSO Global | PMR-Egger intercept | PIVW. Q |
---|---|---|---|---|---|---|---|
1-arachidonoylglycerophosphocholine for anxiety disorders diagnosed by psychiatrists | 0.0042** | 0.026* | 0.0002*** | 0.0096** | 0.149 | 0.338 | 0.207 |
androsterone sulfate for anxiety disorders diagnosed by psychiatrists | 0.0065** | 0.0185* | 7.63 × 10–5*** | 0.0136* | 0.113 | 0.311 | 0.091 |
1-linoleoylglycerophosphoethanolamine for anxiety disorders diagnosed by general practitioners | 0.002** | 0.0148* | 0.0001*** | 0.003** | 0.366 | 0.146 | 0.408 |
1-eicosatrienoylglycerophosphocholine for anxiety disorders diagnosed by general practitioners | 0.001** | 0.0447* | 0.116 | 0.0005*** | 0.696 | 0.440 | 0.670 |
epiandrosterone sulfate for self-reported anxiety | 0.0028** | 0.023* | 0.0027** | 0.007** | 0.554 | 0.249 | 0.620 |